Indeed, several recent studies have suggested that FTO plays an oncogenic role in various types of cancers such as leukemia, brain tumor, breast cancer, gastric cancer, endometrial carcinoma, and cervical squamous cell carcinoma (CSCC) where it is overexpressed (30–32, 78–82). This evidence concerns the gene FTO and leukemia.